Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel network

      Highlights

      • ‘Do-Not-Do’ recommendations were introduced in the UK to reduce inappropriate prescribing.
      • We piloted two dashboards to flag inappropriate prescribing of metformin and aspirin.
      • At baseline, most metformin prescriptions were appropriate; only a fifth were for aspirin.
      • Use of the dashboard reduced inappropriate prescribing of aspirin.
      • It was feasible to use a dashboard to flag inappropriate prescribing.

      Abstract

      Aims

      To pilot two dashboards to monitor prescribing of metformin and aspirin according to the National Institute for Health and Care Excellence (NICE) ‘Do-Not-Do’ recommendations.

      Methods

      This quality assurance programme was conducted in twelve general practices of the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network. We developed dashboards to flag inappropriate prescribing of metformin and aspirin to people with type 2 diabetes mellitus (T2DM). In Phase 1, six practices (Group A) received a dashboard flagging suboptimal metformin prescriptions in people with reduced renal function. The other six practices (Group B) were controls. In Phase 2, Group B were provided a dashboard to flag inappropriate aspirin prescribing and Group A were controls. We used logistic regression to explore associations between dashboard exposure and inappropriate prescribing.

      Results

      The cohort comprised 5644 individuals (Group A, n = 2656; Group B, n = 2988). Half (51.6%, n = 2991) were prescribed metformin of which 15 (0.5%) were inappropriate (Group A, n = 10; Group B, n = 5). A fifth (17.6%, n = 986) were prescribed aspirin of which 828 (84.0%) were inappropriate. During Phase 1, metformin was stopped in 50% (n = 5) of people in Group A, compared with 20% (n = 1) in the control group (Group B); in Phase 2, the odds ratio of inappropriate aspirin prescribing was significantly lower in practices that received the dashboard versus control (0.44, 95%CI 0.27−0.72).

      Conclusions

      It was feasible to use a dashboard to flag inappropriate prescribing. Whilst underpowered to report a change in metformin, we demonstrated a reduction in inappropriate aspirin prescribing.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arnett D.K.
        • Blumenthal R.S.
        • Albert M.A.
        • Buroker A.B.
        • Goldberger Z.D.
        • Hahn E.J.
        • et al.
        2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2019; 140: e596-e646
        • Austin R.P.
        Polypharmacy as a risk factor in the treatment of type 2 diabetes.
        Diabetes Spectr. 2006; 19: 13-16
        • Cosentino F.
        • Grant P.J.
        • Aboyans V.
        • Bailey C.J.
        • Ceriello A.
        • Delgado V.
        • et al.
        2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
        Eur. Heart J. 2020; 41: 255-323
        • Calderón-Larrañaga A.
        • Poblador-Plou B.
        • González-Rubio F.
        • Gimeno-Feliu L.A.
        • Abad-Díez J.M.
        • Prados-Torres A.
        Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?.
        Br. J. Gen. Pract. 2012; 62: e821-6
        • Maughan D.
        • J. A
        Protecting Resources, Promoting Value: a Doctor’s Guide to Cutting Waste in Clinical Care.
        Academy of Medical Royal Colleges, Centre for Sustainable Healthcare, 2014
        • Garner S.
        Disinvestment: the UK experience.
        15th Annual European Congress. 2012;
        • Bryant E.
        • Claire K.
        • Needham R.
        Reducing Inappropriate Polypharmacy in Primary Care Through Pharmacy-led Interventions.
        ([cited 2020 5th January]. Available from:)2019
        • de Lusignan S.
        An educational intervention, involving feedback of routinely collected computer data, to improve cardiovascular disease management in UK primary care.
        Methods Inf. Med. 2007; 46: 57-62
        • Tuti T.
        • Nzinga J.
        • Njoroge M.
        • Brown B.
        • Peek N.
        • English M.
        • et al.
        A systematic review of electronic audit and feedback: intervention effectiveness and use of behaviour change theory.
        Implement. Sci. 2017; 12: 61
        • Burningham Z.
        • Jackson G.L.
        • Kelleher J.
        • Stevens M.
        • Morris I.
        • Cohen J.
        • et al.
        The enhancing quality of prescribing practices for older veterans discharged from the emergency department (EQUIPPED) potentially inappropriate medication dashboard: a suitable alternative to the in-person academic detailing and standardized feedback reports of traditional EQUIPPED?.
        Clin. Ther. 2020; 42: 573-582
        • Dixon B.E.
        • Jabour A.M.
        • Phillips E.O.
        • Marrero D.G.
        Improving medication adherence for chronic disease using integrated e-technologies.
        Stud. Health Technol. Inform. 2013; 192: 929
        • National Institute for Health and Care Excellence
        Type 2 Diabetes in Adults: Management (NICE Guideline 28).
        2015 ([cited 2021 6th January]. Available from: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-pdf-1837338615493)
        • Correa A.
        • Hinton W.
        • McGovern A.
        • van Vlymen J.
        • Yonova I.
        • Jones S.
        • et al.
        Royal College of general practitioners research and surveillance centre (RCGP RSC) sentinel network: a cohort profile.
        BMJ Open. 2016; 6e011092
        • de Lusignan S.
        • Correa A.
        • Smith G.E.
        • Yonova I.
        • Pebody R.
        • Ferreira F.
        • et al.
        RCGP research and surveillance centre: 50 years’ surveillance of influenza, infections, and respiratory conditions.
        Br. J. Gen. Pract. 2017; 67: 440-441
        • Langdown C.
        • Peckham S.
        The use of financial incentives to help improve health outcomes: is the quality and outcomes framework fit for purpose? A systematic review.
        J. Public Health Oxf. (Oxf.). 2014; 36: 251-258
        • McGovern A.
        • Hinton W.
        • Correa A.
        • Munro N.
        • Whyte M.
        • de Lusignan S.
        Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.
        BMJ Open. 2016; 6e012801
        • National Institute for Health and Care Excellence
        Do Not Do Recommendation.
        ([cited 2021 22nd January]. Available from:)2016
        • National Institute for Health and Care Excellence
        Do Not Do Recommendation.
        ([cited 2021 22nd January]. Available from:)2015
        • Li L.
        • Geraghty O.C.
        • Mehta Z.
        • Rothwell P.M.
        Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
        Lancet. 2017; 390: 490-499
        • McNeil J.J.
        • Wolfe R.
        • Woods R.L.
        • Tonkin A.M.
        • Donnan G.A.
        • Nelson M.R.
        • et al.
        Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.
        N. Engl. J. Med. 2018; 379: 1509-1518
        • American Diabetes Association
        Aspirin therapy in diabetes.
        Diabetes Care. 2004; 27: s72-s73
        • Egan M.
        Clinical dashboards: impact on workflow, care quality, and patient safety.
        Crit. Care Nurs. Q. 2006; 29: 354-361
        • Koopman R.J.
        • Kochendorfer K.M.
        • Moore J.L.
        • Mehr D.R.
        • Wakefield D.S.
        • Yadamsuren B.
        • et al.
        A diabetes dashboard and physician efficiency and accuracy in accessing data needed for high-quality diabetes care.
        Ann. Fam. Med. 2011; 9: 398-405
        • Lusignan S.
        • Gallagher H.
        • Jones S.
        • Chan T.
        • van Vlymen J.
        • Tahir A.
        • et al.
        Audit-based education lowers systolic blood pressure in chronic kidney disease: the quality improvement in CKD (QICKD) trial results.
        Kidney Int. 2013; 84: 609-620
        • Anderson D.
        • Zlateva I.
        • Khatri K.
        • Ciaburri N.
        Using health information technology to improve adherence to opioid prescribing guidelines in primary care.
        Clin. J. Pain. 2015; 31: 573-579
        • Peek N.
        • Gude W.T.
        • Keers R.N.
        • Williams R.
        • Kontopantelis E.
        • Jeffries M.
        • et al.
        Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: an interrupted time series analysis.
        PLoS Med. 2020; 17e1003286
        • Bowman L.
        • Mafham M.
        • Wallendszus K.
        • Stevens W.
        • Buck G.
        • Barton J.
        • et al.
        Effects of aspirin for primary prevention in persons with diabetes mellitus.
        N. Engl. J. Med. 2018; 379: 1529-1539
        • Campbell H.E.
        • Stokes E.A.
        • Bargo D.
        • Logan R.F.
        • Mora A.
        • Hodge R.
        • et al.
        Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.
        BMJ Open. 2015; 5e007230
        • Huang E.S.
        • Strate L.L.
        • Ho W.W.
        • Lee S.S.
        • Chan A.T.
        Long-term use of aspirin and the risk of gastrointestinal bleeding.
        Am. J. Med. 2011; 124: 426-433
        • Flory J.H.
        • Hennessy S.
        • Bailey C.J.
        • Inzucchi S.E.
        Reports of lactic acidosis attributed to metformin, 2015-2018.
        Diabetes Care. 2020; 43: 244-246
        • Giaccari A.
        • Solini A.
        • Frontoni S.
        • Del Prato S.
        Metformin benefits: another example for alternative energy substrate mechanism?.
        Diabetes Care. 2021; 44: 647-654
        • Lazarus B.
        • Wu A.
        • Shin J.I.
        • Sang Y.
        • Alexander G.C.
        • Secora A.
        • et al.
        Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study.
        JAMA Intern. Med. 2018; 178: 903-910